BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35036081)

  • 1. Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma.
    Zhong T; Jiang Z; Wang X; Wang H; Song M; Chen W; Yang S
    PeerJ; 2022; 10():e12493. PubMed ID: 35036081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
    Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
    PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma.
    Li F; Jin Y; Pei X; Guo P; Dong K; Wang H; Chen Y; Guo P; Meng LB; Wang Z
    Comput Biol Chem; 2021 Jun; 92():107453. PubMed ID: 33636636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatics analysis to identify the key gene associated with metastatic clear cell renal cell carcinoma.
    Miao S; Song J; Liu Q; Lai J; Wang H; Ran L
    Med Oncol; 2022 Jun; 39(9):128. PubMed ID: 35716215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).
    Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D
    BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
    Sui Y; Lu K; Fu L
    PeerJ; 2021; 9():e11272. PubMed ID: 33976979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
    Wang S; Yu ZH; Chai KQ
    Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Metastasis-Associated Gene Signature of Clear Cell Renal Cell Carcinoma.
    Gao S; Yan L; Zhang H; Fan X; Jiao X; Shao F
    Front Genet; 2020; 11():603455. PubMed ID: 33613617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.
    Wu F; Wu S; Gou X
    Neoplasma; 2018; 65(2):242-252. PubMed ID: 29534586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis.
    Zhang N; Chen W; Gan Z; Abudurexiti A; Hu X; Sang W
    Medicine (Baltimore); 2020 May; 99(21):e20470. PubMed ID: 32481352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma.
    Zheng B; Wang S; Yuan X; Zhang J; Shen Z; Ge C
    BMC Urol; 2023 May; 23(1):82. PubMed ID: 37138262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
    Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A
    Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
    Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
    BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of P4HB is correlated with poor prognosis in human clear cell renal cell carcinoma.
    Zhu Z; He A; Lv T; Xu C; Lin L; Lin J
    Cancer Biomark; 2019; 26(4):431-439. PubMed ID: 31640086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Prognostic Related Hub Genes in Clear-Cell Renal Cell Carcinoma
    Jiang P; Sun TT; Chen CW; Huang RS; Zhong ZM; Lou XJ; Liu G; Wang L; Zuo RH
    Chin Med Sci J; 2021 Jun; 36(2):127-134. PubMed ID: 34231461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
    Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
    BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of TYROBP and FCER1G as Key Genes with Prognostic Value in Clear Cell Renal Cell Carcinoma by Bioinformatics Analysis.
    Wang L; Lin Y; Yuan Y; Liu F; Sun K
    Biochem Genet; 2021 Oct; 59(5):1278-1294. PubMed ID: 33786672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.